Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany, marks ‘International Day of Girls and Women in Science 2025’ together with African First Ladies, and their ...

Shares of Merck and Pfizer are way down from their previous peaks. Merck's lead drug, Keytruda, grew sales by 19% last year, but its era of patent-protected exclusivity is approaching its end.

Merck & Co has said building its cardiovascular ... according to lead investigator Marius Hoeper, of Hannover Medical School in Germany - could lead to a “paradigm shift” in treatment of ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Doctors and their patients discuss the range of services that Duke Cancer Institute provides to teens and younger adults with a history of cancer. Beyond Cancer: Mental Health and Therapy Duke ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Commissions do not affect our editors' opinions or evaluations. The best online banks offer a healthy mix of high APYs, low fees and reasonable minimum requirements. We’ve compared the products ...

Trump Says He Will Rework Global Trading Relations With ‘Reciprocal’ Tariffs President Trump signed a memorandum ordering his advisers to calculate new tariff levels for other countries, a ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial evaluating zilovertamab vedotin in combination with ...